Dr. Bowen leverages his unique background in cancer research, software development, and strategy consulting to lead the team responsible for accelerating patient identification for cancer clinical trials. As a cancer researcher, he focused on pathological identification of tumor differentiation in breast cancers derived from p53, BRCA1/2, ATM and other mutations. More recently, he was a founding leader of the software innovation team at Fuse by Cardinal Health. Dr. Bowen was a Regents Scholar at the University of California, San Diego where he received his doctorate in Biomedical Sciences.
Clinical & Research Tools Showcase:
Deep Lens matches prescreened patients to oncology clinical trials. We accelerate enrollment by coupling our AI platform VIPER with dedicated clinical research staff to decrease the burden on providers across our network of community oncology practices.
Improving Oncology Trial Accrual Rates with AI
The clinical trial landscape has changed. Clinical research teams face new challenges with increasingly complex precision oncology protocols. This showcase will cover how Deep Lens couples experienced clinical staff with AI-backed technology to accelerate patient accrual for precision studies.
The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.